Organovo Holdings (ONVO) Earnings Date & Reports

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well asÂ preclinical data... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ONVO is expected to report earnings to rise 78.57% to -25 cents per share on February 28

Organovo Holdings ONVO Stock Earnings Reports

Q4'24

Est.

$-0.25

Q3'24

Beat

by $0.12

Q2'24

Est.

$-0.23

Q1'24

Beat

by $0.03

Q4'23

Est.

$-0.36

The last earnings report on November 07 showed earnings per share of -14 cents, beating the estimate of -25 cents. With 11.78K shares outstanding, the current market capitalization sits at 3.85M.

View a ticker or compare two or three

Compare

ONVO